Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons With Elevated Triglycerides (200-499) on Statin Therapy
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms EVAPORATE
- 09 Feb 2018 Last checked against ClinicalTrials.gov record.
- 06 Feb 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 24 Jan 2018 Ratinale and trial design published in the Clinical Cardiology.